• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门诊患者对茶碱和苯妥英治疗的依从性。

Outpatient compliance with theophylline and phenytoin therapy.

作者信息

Dowse R, Futter W T

机构信息

School of Pharmaceutical Sciences, Rhodes University, Grahamstown.

出版信息

S Afr Med J. 1991 Dec 7;80(11-12):550-3.

PMID:1745939
Abstract

Poor compliance with prescribed medication is a significant problem in chronic disease states and is often responsible for the apparent failure of therapy. The determinants and extent of non-compliance are commonly incorrectly perceived by doctors. During routine therapeutic drug monitoring of epileptic and asthmatic outpatients at a local day hospital, non-compliance was identified as a significant problem. A compliance study was conducted on 80 epileptic and asthmatic patients to determine the nature and extent of this problem. Non-compliance was measured using four different methods, which were then compared using chi 2 tests. Overall incidence of non-compliance was found to be 63%. Age, sex, standard of education and duration of disease were found to have no association with non-compliance. The most clinically significant finding was that almost half the patients were unaware of the necessity of taking their medication on a continuous basis. No significant differences existed between assessing non-compliance using tablet counts, patient interview and clinic attendance, whereas the method using blood levels gave significantly different results from all the other methods used.

摘要

在慢性病状态下,对规定药物的依从性差是一个重大问题,并且常常是治疗看似失败的原因。医生通常会错误地认识不依从的决定因素和程度。在当地日间医院对癫痫和哮喘门诊患者进行常规治疗药物监测期间,发现不依从是一个重大问题。对80名癫痫和哮喘患者进行了一项依从性研究,以确定该问题的性质和程度。使用四种不同方法测量不依从性,然后使用卡方检验进行比较。发现总体不依从发生率为63%。发现年龄、性别、教育水平和疾病持续时间与不依从无关。最具临床意义的发现是,几乎一半的患者没有意识到持续服药的必要性。使用药片计数、患者访谈和门诊就诊评估不依从性之间没有显著差异,而使用血药浓度的方法与所有其他使用的方法得出的结果有显著差异。

相似文献

1
Outpatient compliance with theophylline and phenytoin therapy.门诊患者对茶碱和苯妥英治疗的依从性。
S Afr Med J. 1991 Dec 7;80(11-12):550-3.
2
Non-compliance in asthmatic children: a study of theophylline levels in a pediatric emergency room population.哮喘儿童的不依从性:儿科急诊室人群中茶碱水平的研究。
Ann Allergy. 1979 Aug;43(2):95-7.
3
Theophylline compliance in asthmatic children.哮喘儿童对茶碱的依从性
Ann Allergy. 1985 Jan;54(1):19-24.
4
Compliance of chronic asthmatics with oral administration of theophylline as measured by serum and salivary levels.
Pediatrics. 1976 Apr;57(4):513-7.
5
Compliance monitoring in epileptic patients.
J Assoc Physicians India. 1993 Jul;41(7):431-2.
6
[Compliance of children with bronchial asthma in long-term therapy with theophylline retard preparations].[儿童支气管哮喘患者长期使用缓释型茶碱制剂治疗的依从性]
Kinderarztl Prax. 1993 Aug;61(6):207-10.
7
Compliance with oral theophylline therapy in asthmatic children.哮喘儿童口服茶碱治疗的依从性。
Ann Allergy. 1985 May;54(5):400-4.
8
Determinants of compliance in epileptic patients.癫痫患者依从性的决定因素。
Epilepsy Res Suppl. 1988;1:135-40.
9
Compliance with pharmacologic prophylaxis and therapy in bronchial asthma.支气管哮喘药物预防和治疗的依从性。
Ann Allergy. 1994 Aug;73(2):135-40.
10
Maintaining theophylline compliance/adherence in severely asthmatic children: the role of psychologic functioning of the child and family.维持重度哮喘儿童对茶碱的依从性:儿童及其家庭心理功能的作用
Ann Allergy Asthma Immunol. 1997 Oct;79(4):311-8. doi: 10.1016/S1081-1206(10)63020-7.

引用本文的文献

1
Evaluation of self-reported medication adherence and its associated factors among epilepsy patients in Hospital Kuala Lumpur.吉隆坡医院癫痫患者自我报告的药物依从性及其相关因素评估。
J Basic Clin Pharm. 2016 Sep;7(4):105-109. doi: 10.4103/0976-0105.189430.
2
Measurement of patient compliance.
Pharm World Sci. 1998 Apr;20(2):73-7. doi: 10.1023/a:1008663215166.
3
The patient perspective. What should a new anti-asthma agent provide?患者视角。一种新型抗哮喘药物应具备哪些特性?
Drugs. 1996;52 Suppl 6:29-35. doi: 10.2165/00003495-199600526-00006.